Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome
✍ Scribed by Norén-Nyström, U; Roos, G; Bergh, A; Botling, J; Lönnerholm, G; Porwit, A; Heyman, M; Forestier, E
- Book ID
- 110058582
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 329 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Early response to therapy is defined as the initial response prior to day 28 of treatment, the conventional time of marrow evaluation. the number of reports linking early response to therapy with the ultimate outcome of childhood acute lymphoblastic leukemia is substantial and growin
## Abstract Three hundred twenty‐six children with bone marrow (BM) relapse of non‐B acute lymphoblastic leukemia (ALL) were stratified according to the time of relapse in three consecutive multicenter trials—ALL‐REZ BFM 83, 85, and 87. Employing an intensive polychemotherapy regimen, extramedullar
## Abstract ## Background In our previous studies, the outcome of high‐risk ALL was still poor. In the present study, all children with ALL were classified into three groups and treated with a new regimen (AL90). ## Patients and Methods Between 1990 and 1996, 220 children with ALL, treated with